S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Laser breakthrough could send stock soaring 2,467% (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Canadian autoworkers ratify new labor agreement with Ford
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
A coal mine fire in southern China's Guizhou province kills 16 people
OTCMKTS:SPHDF

Santhera Pharmaceuticals (SPHDF) Stock Forecast, Price & News

$10.29
0.00 (0.00%)
(As of 09/22/2023 ET)
Compare
Today's Range
$10.29
$10.29
50-Day Range
$0.68
$10.29
52-Week Range
$0.68
$1.20
Volume
N/A
Average Volume
3,788 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

SPHDF stock logo

About Santhera Pharmaceuticals (OTCMKTS:SPHDF) Stock

Santhera Pharmaceuticals Holding AG, a specialty pharmaceutical company, together with its subsidiaries, develops and commercializes medicines for rare neuromuscular and pulmonary diseases with high unmet medical need in the European Union and internationally. The company's lead pipeline candidate includes Vamorolone, which is being developed for the treatments of Duchenne muscular dystrophy (DMD). Its clinical stage pipeline also comprises Lonodelestat to treat cystic fibrosis and other neutrophilic pulmonary diseases, as well as omigapil that treats congenital muscular dystrophies. The company also out-licenses outside North America and France rights to its approved product, Raxone (idebenone), for the treatment of Leber's hereditary optic neuropathy. Santhera Pharmaceuticals Holding AG was founded in 2004 and is headquartered in Pratteln, Switzerland.

SPHDF Price History

SPHDF Stock News Headlines

Santhera Pharmaceuticals reports 1H results
[BREAKING] Pentagon to Spend Billions on "Living Missile"
Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!
[BREAKING] Pentagon to Spend Billions on "Living Missile"
Air Force Magazine calls it "transformational." The Wall Street Journal calls it one of the Pentagon's "highest priorities." National Defense Magazine reports "Eye-popping budget" for it. This small company won the first contract to build them!
Santhera Pharmaceuticals GAAP EPS of -CHF1.17
Santhera Publishes Annual Report 2022
Santhera Pharmaceuticals Holding AG
See More Headlines
Receive SPHDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Santhera Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:SPHDF
CIK
N/A
Fax
N/A
Employees
45
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Dr. Thomas Meier Ph.D. (Age 61)
    Founder & Chairman
    Comp: $93.8k
  • Mr. Dario Eklund (Age 55)
    Chief Exec. Officer
    Comp: $912.62k
  • Mr. Andrew P. Smith CGMA (Age 60)
    FCMA, Chief Financial Officer
  • Mr. Oliver Strub (Age 60)
    Exec. VP, Gen. Counsel & Sec.
  • Mr. Günther Metz Ph.D. (Age 65)
    Head of Bus. Devel. & Exec. VP
  • Mr. Shabir Hasham M.D.
    Chief Medical Officer
  • Ms. Stephanie Brown B.Sc. (Age 62)
    M.B.A., Pres of North America
  • Mr. Marc Schrader
    Head of Technical Devel. & Operations
  • Ms. Eva Kalias
    Head of Investor Relations & Communications
  • Mr. Neville Kodkani M.D.
    Head of Global Marketing & Partner Management













SPHDF Stock - Frequently Asked Questions

How have SPHDF shares performed in 2023?

Santhera Pharmaceuticals' stock was trading at $14.10 at the beginning of the year. Since then, SPHDF stock has decreased by 27.0% and is now trading at $10.2920.
View the best growth stocks for 2023 here
.

Are investors shorting Santhera Pharmaceuticals?

Santhera Pharmaceuticals saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 82,800 shares, a decrease of 27.6% from the August 15th total of 114,300 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 828.0 days.
View Santhera Pharmaceuticals' Short Interest
.

When did Santhera Pharmaceuticals' stock split?

Santhera Pharmaceuticals shares reverse split on Monday, July 3rd 2023. The 1-10 reverse split was announced on Monday, July 3rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 3rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What is Santhera Pharmaceuticals' stock symbol?

Santhera Pharmaceuticals trades on the OTCMKTS under the ticker symbol "SPHDF."

How do I buy shares of Santhera Pharmaceuticals?

Shares of SPHDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Santhera Pharmaceuticals' stock price today?

One share of SPHDF stock can currently be purchased for approximately $10.29.

How can I contact Santhera Pharmaceuticals?

Santhera Pharmaceuticals' mailing address is Hohenrainstrasse 24, Pratteln, Basel-Landschaft (Basle. The official website for the company is www.santhera.com. The company can be reached via phone at (161) 906-8950.

This page (OTCMKTS:SPHDF) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -